Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.49% is 35% below its 5-year average of 0.75%, near the low end of its 5-year range (0.46%–1.16%).
As of the fiscal period ended Tuesday, June 30, 2026. 26.91% below its 12-month average of 0.67%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
0.49%
DEBT TO ASSETS RATIO AVG TTM
0.67%
DEBT TO ASSETS RATIO AVG 3Y
0.67%
DEBT TO ASSETS RATIO AVG 5Y
0.73%
DEBT TO ASSETS RATIO AVG 10Y
1.03%
DEBT TO ASSETS RATIO AVG 15Y
30.79%
DEBT TO ASSETS RATIO AVG 20Y
50.41%
CURRENT VS TTM AVG
-26.91%
CURRENT VS 3Y AVG
-27.65%
CURRENT VS 5Y AVG
-33.14%
CURRENT VS 10Y AVG
-52.73%
CURRENT VS 15Y AVG
-98.42%
CURRENT VS 20Y AVG
-99.04%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+70.55%
vs the sector median at left
Incyte Corporation
Market Cap
$24.28B
Debt to Assets Ratio
0.49%
TTM Avg
0.67%
3Y Avg
0.67%
5Y Avg
0.73%
Market Cap
$24.72B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$25.74B
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$26.03B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.03B
Debt to Assets Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | $24.28B | 0.49% | 0.67% | 0.67% | 0.73% |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.72B | 0.08% | N/A | N/A | N/A |
| BioNTech SE (BNTX)vs › | $23.16B | 0.01% | N/A | N/A | N/A |
| Labcorp Holdings Inc. (LH)vs › | $25.74B | 0.37% | N/A | N/A | N/A |
| STERIS plc (STE)vs › | $22.68B | 0.19% | N/A | N/A | N/A |
| Quest Diagnostics Incorporated (DGX)vs › | $26.03B | 0.38% | N/A | N/A | N/A |
| Waters Corporation (WAT)vs › | $26.07B | 0.21% | N/A | N/A | N/A |
| Moderna, Inc. (MRNA)vs › | $22.32B | 0.11% | N/A | N/A | N/A |
| United Therapeutics Corporation (UTHR)vs › | $22.03B | N/A | N/A | N/A | N/A |
| Viatris Inc. (VTRS)vs › | $20.55B | 0.39% | N/A | N/A | N/A |
Debt/Assets
0.5%
Debt/Equity
0.01
Current Ratio
4.66
Interest Coverage
553.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.49% |
| 2026-03-31 | 0.46% |
| 2025-12-31 | 1.00% |
| 2025-09-30 | 0.65% |
| 2025-06-30 | 0.73% |
| 2025-03-31 | 0.75% |
| 2024-12-31 | 0.80% |
| 2024-09-30 | 0.73% |
| 2024-06-30 | 0.81% |
| 2024-03-31 | 0.52% |
| 2023-12-31 | 0.56% |
| 2023-09-30 | 0.60% |
| 2023-06-30 | 0.64% |
| 2023-03-31 | 0.69% |
| 2022-12-31 | 0.71% |
| 2022-09-30 | 0.76% |
| 2022-06-30 | 0.82% |
| 2022-03-31 | 0.87% |
| 2021-12-31 | 0.91% |
| 2021-09-30 | 1.04% |
| 2021-06-30 | 1.16% |
| 2021-03-31 | 1.26% |
| 2020-12-31 | 1.33% |
| 2020-09-30 | 1.74% |
| 2020-06-30 | 1.92% |
| 2020-03-31 | 2.19% |
| 2019-12-31 | 1.76% |
| 2019-09-30 | 1.90% |
| 2019-06-30 | 1.71% |
| 2019-03-31 | 0.64% |
| 2018-12-31 | 1.37% |
| 2018-09-30 | 0.99% |
| 2018-06-30 | 1.02% |
| 2018-03-31 | 1.05% |
| 2017-12-31 | 1.04% |
| 2017-09-30 | 1.00% |
| 2017-06-30 | 1.43% |
| 2017-03-31 | 2.59% |
| 2016-12-31 | 39.76% |
| 2016-09-30 | 41.67% |
| 2016-06-30 | 44.82% |
| 2016-03-31 | 56.85% |
| 2015-12-31 | 61.53% |
| 2015-09-30 | 66.95% |
| 2015-06-30 | 70.94% |
| 2015-03-31 | 80.86% |
| 2014-12-31 | 81.34% |
| 2014-09-30 | 86.76% |
| 2014-06-30 | 99.15% |
| 2014-03-31 | 99.76% |
| 2013-12-31 | 105.08% |
| 2013-09-30 | 52.36% |
| 2013-06-30 | 66.97% |
| 2013-03-31 | 102.19% |
| 2012-12-31 | 100.20% |
| 2012-09-30 | 112.84% |
| 2012-06-30 | 105.24% |
| 2012-03-31 | 109.73% |
| 2011-12-31 | 96.11% |
| 2011-09-30 | 83.58% |
| 2011-06-30 | 73.09% |
| 2011-03-31 | 65.04% |
| 2010-12-31 | 59.94% |
| 2010-09-30 | 62.00% |
| 2010-06-30 | 57.29% |
| 2010-03-31 | 55.25% |
| 2009-12-31 | 62.20% |
| 2009-09-30 | 100.97% |
| 2009-06-30 | 252.32% |
| 2009-03-31 | 210.23% |
| 2008-12-31 | 170.48% |
| 2008-09-30 | 148.73% |
| 2008-06-30 | 191.11% |
| 2008-03-31 | 164.08% |
| 2007-12-31 | 140.21% |
| 2007-09-30 | 133.54% |
| 2007-06-30 | 121.55% |
| 2007-03-31 | 114.85% |
| 2006-12-31 | 104.95% |
| 2006-09-30 | 99.11% |
| 2006-06-30 | 92.95% |
| 2006-03-31 | 87.43% |
| 2005-12-31 | 91.38% |
| 2005-09-30 | 85.89% |
| 2005-06-30 | 80.04% |
| 2005-03-31 | 77.69% |
| 2004-12-31 | 73.27% |
| 2004-09-30 | 80.52% |
| 2004-06-30 | 77.60% |
| 2004-03-31 | 71.71% |
| 2003-12-31 | 44.21% |
| 2003-09-30 | 40.41% |
| 2003-06-30 | 36.52% |
| 2003-03-31 | 34.60% |
| 2002-12-31 | 31.16% |
| 2002-09-30 | 28.55% |
